SUMMARY Plasminogen in full term newbom infants has been measured by functional and immunological assays. Plasminogen functional activity and antigen concentration in newborn infants were about 44% and 48% of adult values respectively. Physiological activation kinetics of plasminogen in undiluted plasma at pH 7-4 and 37°C using various concentrations of streptokinase and urokinase showed no significant difference in the rate of plasmin generation between plasminogen from newborn infants and adult plasminogen.
Plasminogen is a protein zymogen in plasma which is converted to plasmin by activators released from various sources in the body. In vivo the plasminogen-plasmin system is a major part of the fibrinolytic mechanism. Functional abnormalities of several coagulation proteins, especially fibrinogen'-3 and prothrombin,45 have been described in full term newborn infants. Estelles et a!6 studied plasminogen amino acids in full term newborn infants and found, besides small qualitative anomalies, a decrease in the number of amino acid residues per mole of protein. These abnonnalities coupled with a decrease in plasminogen levels suggest the possible existence of dysfunctional plasminogen in full term newborn infants.
We have investigated plasminogen functional activity in the plasma of full term newborn infants under physiological conditions at pH 7.4 Mean antiplasmin activity was 103% + 29% in adult plasma and 67% + 25*9% in plasma from newborn infants.
There were no significant differences in the velocities of plasminogen activation for plasminogens from adults and from newborn infants using two different activators and various concentrations. group.bmj.com on October 13, 2017 -Published by http://jcp.bmj.com/ Downloaded from that the data points for each activator will fall on a straight line on a log-log plot (Figure) .
The increase in plasmin activity with activator concentration reflects a fall in the a2-plasmin inhibitor concentration. Two facts should be mentioned at this point. Firstly, the observed fibrinolytic activity is that of free plasmin since Harpel eta!9 have shown that in the presence of a2-plasmin inhibitor oa2-macroglobulin does not bind plasmin to any appreciable extent. Secondly, there is no appreciable competition between P-nitroaniline and a2-plasmin inhibitor under the conditions of the experiment.8 Wiman et al ' showed that P-nitroaniline competes appreciably with a2 plasmin inhibitor only at high substrate concentration and low a2-antiplasmin concentration. At physiological concentrations of a2-plasmin inhibitor such competition becomes minimal, as shown by the exponential rise of plasmin activity with increase in activator concentration while the tripeptide substrate concentration is kept constant.
Wohl et ar showed that large changes in plasminogen concentration will produce small or insignificant changes in the observable velocities. This consideration verifies that an observed variation in kinetic behaviour represents a substantial departure from normal of the plasminogen species. Urokinase did not activate plasminogen in plasma as effectively as streptokinase (Figure) . The extremely slow increase in the observable velocities indicates that the urokinase inhibitor effect is substantial. Morai et all" showed a pronounced inhibition of urokinase by a2-plasmin inkl<bitor. This could explain the peculiar urokinase results in plasma.
In studies of the fibrinolytic system of newborn infants, plasminogen levels were found to be low in plasma from full term newborn infants and in preterm newborn infants '4-16 
